نتائج البحث - Jean‐Philippe Defour

  • يعرض 1 - 14 نتائج من 14
تنقيح النتائج
  1. 1
    The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin

    The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin حسب Leila N. Varghese, Jean‐Philippe Defour, C. Pecquet, Stefan N. Constantinescu

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Adult haemophagocytic lymphohistiocytosis: a review

    Adult haemophagocytic lymphohistiocytosis: a review حسب Halil Yıldız, Eric Van Den Neste, Jean‐Philippe Defour, Étienne Danse, Jean Cyr Yombi

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    What is the normal value of the neutrophil-to-lymphocyte ratio?

    What is the normal value of the neutrophil-to-lymphocyte ratio? حسب Patrice Forget, Céline Khalifa, Jean‐Philippe Defour, Dominique Latinne, Marie-Cécile Van Pel, Marc De Kock

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Tryptophan at the transmembrane–cytosolic junction modulates thrombopoietin receptor dimerization and activation

    Tryptophan at the transmembrane–cytosolic junction modulates thrombopoietin receptor dimerization and activation حسب Jean‐Philippe Defour, Miki Itaya, Vitalina Gryshkova, Ian Brett, C. Pecquet, Takeshi Sato, Steven O. Smith, Stefan N. Constantinescu

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Short telomeres increase the risk of severe COVID-19

    Short telomeres increase the risk of severe COVID-19 حسب Antoine Froidure, Manon Mahieu, Delphine Hoton, Pierre‐François Laterre, Jean Cyr Yombi, Sandra Koenig, Benoît Ghaye, Jean‐Philippe Defour, Anabelle Decottignies

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Orientation-specific signalling by thrombopoietin receptor dimers

    Orientation-specific signalling by thrombopoietin receptor dimers حسب Judith Staerk, Jean‐Philippe Defour, C. Pecquet, Emilie Leroy, Hélène Antoine‐Poirel, Ian Brett, Miki Itaya, Steven O. Smith, William Vainchenker, Stefan N. Constantinescu

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency

    Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency حسب Maria Veiga‐da‐Cunha, Nathalie Chevalier, Xavier Stéphenne, Jean‐Philippe Defour, Nicole Paczia, Alina Ferster, Younès Achouri, Joseph P. Dewulf, Carole L. Linster, Guido T. Bommer, Emile Van Schaftingen

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development

    Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development حسب Thomas Balligand, Younès Achouri, C. Pecquet, Gilles Gaudray, Didier Colau, Eva Hug, Yacine Rahmani, Vincent Stroobant, Isabelle Plo, William Vainchenker, Róbert Královics, Benoı̂t J. Van den Eynde, Jean‐Philippe Defour, Stefan N. Constantinescu

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes

    Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes حسب C. Pecquet, Carmen C. Diaconu, Judith Staerk, Michael Girardot, Caroline Marty, Yohan Royer, Jean‐Philippe Defour, Alexandra Dusa, Rodolphe Besancenot, Stéphane Giraudier, Jean‐Luc Villeval, Laurent Knoops, Pierre J. Courtoy, William Vainchenker, Stefan N. Constantinescu

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Combination treatment for myeloproliferative neoplasms using <scp>JAK</scp> and pan‐class I <scp>PI</scp>3K inhibitors

    Combination treatment for myeloproliferative neoplasms using <scp>JAK</scp> and pan‐class I <scp>PI</scp>3K inhibitors حسب Meng Ling Choong, C. Pecquet, Vishal Pendharkar, Carmen C. Diaconu, Jacklyn Wei Yan Yong, Shi Tai, Si Fang Wang, Jean‐Philippe Defour, Kanda Sangthongpitag, Jean‐Luc Villeval, William Vainchenker, Stefan N. Constantinescu, May Ann Lee

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants

    Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants حسب Ilyas Chachoua, C. Pecquet, Mira El-Khoury, Harini Nivarthi, Roxana-Irina Albu, Caroline Marty, Vitalina Gryshkova, Jean‐Philippe Defour, Gaëlle Vertenoeil, Anna Ngo, Ann Koay, Hana Raslová, Pierre J. Courtoy, Meng Ling Choong, Isabelle Plo, William Vainchenker, Róbert Královics, Stefan N. Constantinescu

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants

    Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants حسب C. Pecquet, Ilyas Chachoua, Anita Roy, Thomas Balligand, Gaëlle Vertenoeil, Emilie Leroy, Roxana-Irina Albu, Jean‐Philippe Defour, Harini Nivarthi, Eva Hug, Erica Xu, Yasmine Ould-Amer, Céline Mouton, Didier Colau, Didier Vertommen, Myat Marlar Shwe, Caroline Marty, Isabelle Plo, William Vainchenker, Róbert Královics, Stefan N. Constantinescu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients

    Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients حسب Xénia Cabagnols, Fabrizia Favale, Florence Pasquier, Kahia Messaoudi, Jean‐Philippe Defour, Jean‐Christophe Ianotto, Christophe Marzac, J P Le Couedic, Nathalie Droin, Ilyas Chachoua, Rémi Favier, M’Boyba Diop, Valérie Ugo, Nicole Casadevall, Najet Debili, Hana Raslová, Christine Bellanné-Chantelot, Stefan N. Constantinescu, Olivier Bluteau, Isabelle Plo, William Vainchenker

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

    Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution حسب Xénia Cabagnols, Jean‐Philippe Defour, Valérie Ugo, Jean‐Christophe Ianotto, Pascal Mossuz, Julie Mondet, François Girodon, Jean Alexandre, Olivier Mansier, Jean‐François Viallard, Éric Lippert, Anne Murati, Julien Mozziconacci, Pascale Saussoy, Marie-Christine Vekemans, L. Knoops, Florence Pasquier, Vincent Ribrag, Éric Solary, Isabelle Plo, Stefan N. Constantinescu, Nicole Casadevall, William Vainchenker, Christophe Marzac, Olivier Bluteau

    منشور في 2014
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: